RINVOQ tablets 7.5 mg (Upadacitinib hydrate), manufactured by AbbVie (YJ code: 3999048G1028, standard: 7.5 mg 1 tablet), is a Janus kinase (JAK) inhibitor. It is used to treat various inflammatory conditions in adults and some pediatric patients, including moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, ulcerative colitis, and Crohn’s disease.
RINVOQ tablets 7.5 mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
